Press Release: Having established itself as a distinctive CDMO supporter of the pharma/biotech innovation community (July2025), Neva is pleased to unveil further opportunities as a true collaborator for early-stage pharma/biotech innovators.
In addition to continuing to provide its standard CDMO services, Neva now welcomes queries about how we may be able to help with the various unique challenges encountered by early-stage pharma/biotech innovators.
Read the full press release here